RecruitingNot ApplicableNCT07258316

High Intensity Interval Training in Pre and Postmenopausal Women With Type II Diabetes.

Comparative Effects of High-Intensity Interval Training in Pre and Postmenopausal Women With Type II Diabetes Mellitus


Sponsor

Riphah International University

Enrollment

45 participants

Start Date

Sep 25, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Diabetes Mellitus (DM), a chronic metabolic disease-causing chronic hyperglycemia. Globally more than 90% cases are of type II diabetes mellitus (T2DM). Around 537 million adults worldwide had diabetes but according to data from Pakistan, female sufferers are marginally higher (26.4%) as compared to men (25.1%). The main causes of DM II are genetic predispositions, including consanguinity, dietary changes, urbanization and sedentary lifestyles. It is reported that postmenopausal status is linked to worsened glycemic control, increased visceral adiposity and and inflammation, and women before menopause generally have improved lipid metabolism and insulin sensitivity. HIIT provides powerful and time-efficient benefits by alternating high-intensity workouts (85-95% HR\_Max) with recovery.


Eligibility

Sex: FEMALEMin Age: 40 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether high-intensity interval training (HIIT) — short bursts of intense exercise alternated with recovery periods — can improve blood sugar control and other health outcomes in women with type 2 diabetes, regardless of menopausal status. **You may be eligible if...** - You are a woman between 40 and 65 years old - You have been diagnosed with type 2 diabetes by a doctor - You are either premenopausal (regular periods) or postmenopausal (no periods for 12+ months) - You have not done any structured exercise in the past 6 months - You are willing to follow the supervised HIIT program **You may NOT be eligible if...** - You have heart disease, orthopedic injuries, or other conditions that make intense exercise unsafe - You currently use insulin or hormone replacement therapy - You have cognitive impairment or a psychiatric condition Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHigh Intensity Interval Training (warm up, Mat exercises,cycling,HIIT exercises,cool down)

This will include 8 weeks of plan with total 27 sessions 3 times a week and each session will include warm up exercises ( Treadmill (Incline and Reverse), Mat Exercises (Cobra, Cat/camel stretches, Superman, Aeroplane and Skydiving exercises)and Cycling (Seated and un-supported). this will be of 10-15 minutes. Then HIIT exercises which includes High knees, Push ups, Russian crunches, Battle ropes, Weighted squats, Planks, Seated rows and Jumping jacks. Then cool- down exercises will be of 10-15 minutes and this will includes Full body Stretches (Quadriceps, Hamstrings, Piriformis, Calfs, Biceps, Triceps, Rhomboids, IT band, Trapezius, and Chest Stretches), whole exercise plan will take 60-90 minutes.

OTHERControl (warm up, Mat exercises,cycling,Resistance exercises,cool down)

This group will includes also recieve 8 weeks of exercises plan for 3/week warmup exercises same as the experimental group such as Treadmill (Incline and Reverse), Mat Exercises (Cobra, Cat/camel stretches, Superman, Aeroplane and Skydiving exercises)and Cycling (Seated and un-supported) forv about 10-15 miutes Resistance Exercises like (LAT Pull down, Leg Curls, Leg Extension, Hips Adductor/ Abductors, Seated Rowing, Rear deltoid machine). the progression will be increased gradually. Cool down exercises includes full body streching and the whole session will be of 60-90 minutes


Locations(1)

Ginnastic Health Centre, Islamabad

Islamabad, Islamabad Capital Territory, Pakistan, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07258316


Related Trials